American International Group, Inc. Next Cure, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.6 - $10.28 $72,990 - $98,729	-9,604 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$9.81 - $13.88 $245 - $347	25 Added 0.26%	9,604 $96,000
Q4 2020 Feb 12, 2021	SELL	$9.47 - $12.43 $2,594 - $3,405	-274 Reduced 2.78%	9,579 $104,000
Q3 2020 Nov 04, 2020	SELL	$8.15 - $21.17 $1,825 - $4,742	-224 Reduced 2.22%	9,853 $87,000
Q2 2020 Aug 12, 2020	BUY	$21.19 - $40.2 $32,865 - $62,350	1,551 Added 18.19%	10,077 $216,000
Q1 2020 May 04, 2020	SELL	$32.32 - $58.37 $9,405 - $16,985	-291 Reduced 3.3%	8,526 $316,000
Q4 2019 Feb 05, 2020	BUY	$25.0 - $92.22 $173,175 - $638,807	6,927 Added 366.51%	8,817 $497,000
Q3 2019 Nov 08, 2019	BUY	$15.73 - $41.6 $817 - $2,163	52 Added 2.83%	1,890 $58,000
Q2 2019 Aug 13, 2019	BUY	$14.16 - $20.64 $26,026 - $37,936	1,838 New	1,838 $28,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.